“After the Gold Rush” – Immuno-oncology (IO) Article by Immunomic and Scientific American

“After the Gold Rush” – Immuno-oncology (IO) Article by Immunomic and Scientific American
<span>Scientific American custom media and Immunomic Therapeutics, Inc. wrote this article titled, &ldquo;After the Gold Rush.&rdquo; Immuno-oncology (IO) has seen a flood of advancements, investment deals and partnerships, but the climate is changing. How might IO 2.0 drive companies to operate and partner differently? Click here to read:...</span>

Scientific American custom media and Immunomic Therapeutics, Inc. wrote this article titled, “After the Gold Rush.”

Immuno-oncology (IO) has seen a flood of advancements, investment deals and partnerships, but the climate is changing. How might IO 2.0 drive companies to operate and partner differently?

Click here to read:  https://www.scientificamerican.com/custom-media/after-the-gold-rush/

Source: www.immunomix.com